PMID- 24177245 OWN - NLM STAT- MEDLINE DCOM- 20140930 LR - 20140130 IS - 1432-0738 (Electronic) IS - 0340-5761 (Linking) VI - 88 IP - 2 DP - 2014 Feb TI - "Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites. PG - 515-31 LID - 10.1007/s00204-013-1147-9 [doi] AB - 3,4-Methylenedioxymethamphetamine (MDMA; "ecstasy") is a recreational hallucinogenic drug of abuse known to elicit neurotoxic properties. Hepatic formation of neurotoxic metabolites is thought to play a major role in MDMA-related neurotoxicity, though the mechanisms involved are still unclear. Here, we studied the neurotoxicity mechanisms and stability of MDMA and 6 of its major human metabolites, namely alpha-methyldopamine (alpha-MeDA) and N-methyl-alpha-methyldopamine (N-Me-alpha-MeDA) and their correspondent glutathione (GSH) and N-acetyl-cysteine (NAC) conjugates, under normothermic (37 degrees C) or hyperthermic conditions (40 degrees C), using cultured SH-SY5Y differentiated cells. We showed that MDMA metabolites exhibited toxicity to SH-SY5Y differentiated cells, being the GSH and NAC conjugates more toxic than their catecholic precursors and MDMA. Furthermore, whereas the toxicity of the catechol metabolites was potentiated by hyperthermia, NAC-conjugated metabolites revealed higher toxicity under normothermia and GSH-conjugated metabolites-induced toxicity was temperature-independent. Moreover, a time-dependent decrease in extracellular concentration of MDMA metabolites was observed, which was potentiated by hyperthermia. The antioxidant NAC significantly protected against the neurotoxic effects of MDMA metabolites. MDMA metabolites increased intracellular glutathione levels, though depletion in thiol content was observed in MDMA-exposed cells. Finally, the neurotoxic effects induced by the MDMA metabolite N-Me-alpha-MeDA involved caspase 3 activation. In conclusion, this study evaluated the stability of MDMA metabolites in vitro, and demonstrated that the catechol MDMA metabolites and their GSH and NAC conjugates, rather than MDMA itself, exhibited neurotoxic actions in SH-SY5Y differentiated cells, which were differently affected by hyperthermia, thus highlighting a major role for reactive metabolites and hyperthermia in MDMA's neurotoxicity. FAU - Barbosa, Daniel Jose AU - Barbosa DJ AD - REQUIMTE (Rede de Quimica e Tecnologia), Toxicology Laboratory, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal, daniel.barbosa@ff.up.pt. FAU - Capela, Joao Paulo AU - Capela JP FAU - Silva, Renata AU - Silva R FAU - Ferreira, Luisa Maria AU - Ferreira LM FAU - Branco, Paula Serio AU - Branco PS FAU - Fernandes, Eduarda AU - Fernandes E FAU - Bastos, Maria Lourdes AU - Bastos ML FAU - Carvalho, Felix AU - Carvalho F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131101 PL - Germany TA - Arch Toxicol JT - Archives of toxicology JID - 0417615 RN - 4764-17-4 (3,4-Methylenedioxyamphetamine) RN - 555-64-6 (alpha-methyldopamine) RN - EC 3.4.22.- (Caspase 3) RN - GAN16C9B8O (Glutathione) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - R7339QLN1C (Deoxyepinephrine) RN - WYQ7N0BPYC (Acetylcysteine) SB - IM MH - 3,4-Methylenedioxyamphetamine/metabolism/toxicity MH - Acetylcysteine/metabolism/pharmacology MH - Caspase 3/metabolism MH - Cell Death/drug effects MH - Cell Differentiation/*drug effects MH - Cell Line/drug effects MH - Deoxyepinephrine/analogs & derivatives/metabolism/toxicity MH - Fever/*chemically induced/metabolism MH - Glutathione/metabolism MH - Humans MH - Mitochondria/drug effects/metabolism MH - N-Methyl-3,4-methylenedioxyamphetamine/*metabolism/pharmacokinetics/*toxicity MH - Neurons/*drug effects/metabolism MH - Neurotoxicity Syndromes/metabolism/pathology MH - Temperature EDAT- 2013/11/02 06:00 MHDA- 2014/10/01 06:00 CRDT- 2013/11/02 06:00 PHST- 2013/08/13 00:00 [received] PHST- 2013/10/07 00:00 [accepted] PHST- 2013/11/02 06:00 [entrez] PHST- 2013/11/02 06:00 [pubmed] PHST- 2014/10/01 06:00 [medline] AID - 10.1007/s00204-013-1147-9 [doi] PST - ppublish SO - Arch Toxicol. 2014 Feb;88(2):515-31. doi: 10.1007/s00204-013-1147-9. Epub 2013 Nov 1.